Unquote Private Equity Podcast: H1 review special
With the first half of 2021 now in the books, the team looks at key takeaways and numbers across deal-doing and fundraising, and ponders where the market might be headed.
More on Industry
Novalpina to lose control of EUR 1bn debut fund
GP was founded in 2017 and is notably invested in Israeli spyware business NSO Group
Carlyle raises USD 18.2bn in H1 2021
Increase in AUM is principally driven by a strong haul for the real estate and credit strategies
Capiton raises top-up single asset fund for KD Pharma
GP completed its first single-asset deal for KD Pharma in 2019, having acquired the company in 2013
Eurazeo NAV per share hits record high
AUM grew by +39% over the 12 months to June 2021, to reach €25.6bn
Latest News
Ambienta sells Calucem to Cementos Molins in EUR 150m deal
Calucem reports a turnover of EUR 58m, with an EBITDA of EUR 16m
Sanne board to recommend Apex offer
Should Apex make a firm offer, Cinven would have to significantly up its own bid for the fund administrator
Lonsdale sells Charles Cameron to Penta's Socium Group
Third exit announced by Lonsdale this year, and the second from its 2016 fund
PAI explores Refresco exit
Paris-based private equity firm is exploring options around a dual-track process